Neurogenesis in Alzheimers Disease: A Realistic Alternative to Neuronal Degeneration?

Author(s): Rocio E. Gonzalez-Castaneda, Alma Y. Galvez-Contreras, Sonia Luquin, Oscar Gonzalez-Perez.

Journal Name: Current Signal Transduction Therapy

Volume 6 , Issue 3 , 2011

Become EABM
Become Reviewer

Abstract:

Neural stem cells (NSC) are cells that have the capacity to generate multiple types of differentiated brain cells. In conditions in which there is a loss of key functional cell groups, such as neurons, inducing or introducing neural stem cells to replace the function of those cells that were lost during the disease has the greatest potential therapeutic applications. Indeed, the achievement of one of the main objectives of various investigations is already on the horizon for some conditions, such as Alzheimers disease. It is not known whether impaired neurogenesis contributes to neuronal depletion and cognitive dysfunction in Alzheimers disease (AD). The results of the different investigations are controversial; some studies have found that neurogenesis is increased in AD brains, but others have not.

Keywords: Neurodegenerative disease, Alzheimer's Disease, neurogenesis, neural stem cells, cell death, pEGFR, EGFR, Endocytosis, Gefitinib, Endosomes, Lysosomes, Nucleus, NSCLC

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 6
ISSUE: 3
Year: 2011
Page: [314 - 319]
Pages: 6
DOI: 10.2174/157436211797483949
Price: $58

Article Metrics

PDF: 2